Lexaria Bioscience Corp. (LEXX) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Lexaria Bioscience Corp. (LEXX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $12.5M, listed on NASDAQ, employing roughly 7 people, carrying a beta of 0.36 to the broader market. Lexaria Bioscience Corp. Led by Richard C. Christopher, public since 2021-01-12.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for LEXX as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →